MedCap AB (publ) Total Assets

Latest as of March 2026: Skr2.70 Billion SEK ≈ $290.25 Million USD

MedCap AB (publ) total assets. Based on the latest financial reports, MedCap AB (publ) (MCAP) holds total assets worth Skr2.70 Billion SEK (≈ $290.25 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see MedCap AB (publ) market cap and net worth for the company's overall valuation and market capitalisation.

Total Assets of MedCap AB (publ) (2007–2025)

Total assets of MedCap AB (publ) from 2007 to 2025. This chart illustrates how MedCap AB (publ)'s total assets have evolved over time, based on quarterly financial data. See MedCap AB (publ) (MCAP) share price today for real-time trading data and today's change.

MedCap AB (publ) - Asset Composition Analysis

MedCap AB (publ) Total Assets Breakdown (December 2025)

MedCap AB (publ) total assets breakdown as of December 2025. MedCap AB (publ)'s total assets of Skr2.70 Billion consist of 38.0% current assets and 62.0% non-current assets.

Asset Category Amount (SEK) % of Total Assets
Cash & Equivalents Skr370.40 Million 14.2%
Accounts Receivable Skr349.60 Million 13.4%
Inventory Skr271.40 Million 10.4%
Property, Plant & Equipment Skr379.20 Million 14.6%
Intangible Assets Skr566.30 Million 21.7%
Goodwill Skr662.70 Million 25.4%

Asset Composition Trend (2007–2025)

This chart illustrates how MedCap AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of MedCap AB (publ) to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: MedCap AB (publ)'s current assets represent 38.0% of total assets in 2025, an increase from 34.7% in 2007.
  • Cash Position: Cash and equivalents constituted 14.2% of total assets in 2025, up from 4.4% in 2007.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 46.0% of total assets, an increase from 14.0% in 2007.
  • Asset Diversification: The largest asset category is goodwill at 25.4% of total assets.

MedCap AB (publ) Competitors by Total Assets

Key competitors of MedCap AB (publ) based on total assets are shown below.

Company Country Total Assets
Shenzhen New Industries Biomedical
SHE:300832
China CN¥9.58 Billion
Double Medical Technology Inc
SHE:002901
China CN¥5.03 Billion
BMC Medical Co. Ltd. A
SHE:301367
China CN¥3.59 Billion
SS Innovations International Inc. Common Stock
NASDAQ:SSII
USA $96.98 Million
Emvision Medical Devices Ltd
AU:EMV
Australia AU$24.94 Million
Sequana Medical NV
BR:SEQUA
Belgium €14.57 Million
Hironic Co. Ltd
KQ:149980
Korea ₩80.01 Billion
DRGEM Corporation
KQ:263690
Korea ₩131.65 Billion

MedCap AB (publ) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.10 2.67 1.80
Quick Ratio 1.53 1.83 1.24
Cash Ratio 0.00 0.92 0.55
Working Capital Skr572.60 Million Skr570.70 Million Skr199.00 Million

MedCap AB (publ) - Advanced Valuation Insights

This section examines the relationship between MedCap AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.01
Latest Market Cap to Assets Ratio 0.34
Asset Growth Rate (YoY) 30.9%
Total Assets Skr2.61 Billion
Market Capitalization $891.39 Million USD

Valuation Analysis

Below Book Valuation: The market values MedCap AB (publ)'s assets below their book value (0.34x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: MedCap AB (publ)'s assets grew by 30.9% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for MedCap AB (publ) (2007–2025)

The table below shows the annual total assets of MedCap AB (publ) from 2007 to 2025.

Year Total Assets Change
2025-12-31 Skr2.61 Billion
≈ $280.45 Million
+30.86%
2024-12-31 Skr1.99 Billion
≈ $214.31 Million
+19.81%
2023-12-31 Skr1.66 Billion
≈ $178.88 Million
+16.29%
2022-12-31 Skr1.43 Billion
≈ $153.82 Million
+22.21%
2021-12-31 Skr1.17 Billion
≈ $125.86 Million
+8.16%
2020-12-31 Skr1.08 Billion
≈ $116.37 Million
+28.37%
2019-12-31 Skr842.30 Million
≈ $90.64 Million
+25.92%
2018-12-31 Skr668.90 Million
≈ $71.98 Million
+11.45%
2017-12-31 Skr600.20 Million
≈ $64.59 Million
+6.58%
2016-12-31 Skr563.16 Million
≈ $60.61 Million
-11.55%
2015-12-31 Skr636.73 Million
≈ $68.52 Million
+15.95%
2014-12-31 Skr549.16 Million
≈ $59.10 Million
-8.63%
2013-12-31 Skr601.01 Million
≈ $64.68 Million
+64.77%
2012-12-31 Skr364.76 Million
≈ $39.25 Million
+17.40%
2011-12-31 Skr310.70 Million
≈ $33.44 Million
+0.22%
2010-12-31 Skr310.03 Million
≈ $33.36 Million
+1.70%
2009-12-31 Skr304.84 Million
≈ $32.81 Million
+51.96%
2008-12-31 Skr200.60 Million
≈ $21.59 Million
+2.59%
2007-12-31 Skr195.54 Million
≈ $21.04 Million
--

About MedCap AB (publ)

ST:MCAP Sweden Medical Devices
Market Cap
$891.39 Million
Skr8.28 Billion SEK
Market Cap Rank
#9037 Global
#151 in Sweden
Share Price
Skr551.50
Change (1 day)
-1.34%
52-Week Range
Skr453.00 - Skr600.50
All Time High
Skr670.00
About

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; an… Read more